CN114106059B - Ionic carbamyl iron carbonyl compound, and preparation method and application thereof - Google Patents
Ionic carbamyl iron carbonyl compound, and preparation method and application thereof Download PDFInfo
- Publication number
- CN114106059B CN114106059B CN202111396543.6A CN202111396543A CN114106059B CN 114106059 B CN114106059 B CN 114106059B CN 202111396543 A CN202111396543 A CN 202111396543A CN 114106059 B CN114106059 B CN 114106059B
- Authority
- CN
- China
- Prior art keywords
- ionic
- iron carbonyl
- compound
- preparation
- carbamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940087654 iron carbonyl Drugs 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000001728 carbonyl compounds Chemical class 0.000 title description 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 title description 6
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910002091 carbon monoxide Inorganic materials 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 18
- -1 carbamoyl iron carbonyl compound Chemical class 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 150000001412 amines Chemical class 0.000 claims abstract description 5
- 239000003302 ferromagnetic material Substances 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 52
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 12
- 229910052786 argon Inorganic materials 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000002243 precursor Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000012512 characterization method Methods 0.000 description 7
- 229940125782 compound 2 Drugs 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
- 239000011261 inert gas Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000004452 microanalysis Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-DYCDLGHISA-N deuterium hydrogen oxide Chemical compound [2H]O XLYOFNOQVPJJNP-DYCDLGHISA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
- H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
- H01F1/032—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of hard-magnetic materials
- H01F1/10—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of hard-magnetic materials non-metallic substances, e.g. ferrites, e.g. [(Ba,Sr)O(Fe2O3)6] ferrites with hexagonal structure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Power Engineering (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses an ionic carbamoyl iron carbonyl compound, which has a structure shown as a formula (1):the invention discloses a preparation method of the compound, which comprises the following specific steps: under certain solvent and reaction conditions, the catalyst consists of [ Fe (CO) 4 Br 2 ]Reacting with proper amount of organic amine for a certain time, and separating and purifying to obtain the target compound. The invention also discloses application of the compounds in the aspect of slow release of carbon monoxide drugs and application of the compounds as precursors in preparation of ferromagnetic materials.
Description
Technical Field
The invention relates to a novel ionic carbamoyl iron carbonyl compound and a preparation method thereof, and application of the compound in the fields of chemical industry, materials, biology, medicine and the like.
Background
Iron carbonyls are a class of classical transition metal carbonyls. Because of the richness of non-carbonyl ligand and iron center valence state and the diversity of carbonyl coordination forms, the iron carbonyl compound has a relatively rich structure and has wide application in the fields of organic synthesis, biological inorganic, functional coordination compound, catalytic material and the like. Carbamoyl iron carbonyl compounds are a novel class of compounds and, due to their structural similarity to monoiron hydrogenases, there are several reports in the field of biomimetic catalytic hydrogen production (inorg. Chem.,2020,59,2548-2561;Dalton Trans, 2013,42,8140-8146; angelw. Chem., int. Ed.,2010,49,7508-7511). In addition, iron carbonyl compounds can release carbon monoxide (CO) under certain conditions, and thus have also been reported in research on the medicinal value of carbon monoxide (chord. Chem. Rev.,2021,429,213634). However, the currently reported iron-based carbon monoxide slow release agent has to be further optimized in terms of water solubility, stability, release controllability, biocompatibility and the like so as to obtain wider biological application.
Disclosure of Invention
The invention aims to provide a novel ionic carbamyl iron carbonyl compound and a preparation method thereof.
It is another object of the present invention to provide the use of such compounds in carbon monoxide slow release drug research.
It is also an object of the present invention to provide the use of such compounds for the preparation of ferromagnetic materials.
To achieve these objects and other advantages and in accordance with the purpose of the invention, there is provided a novel carbamoyl iron carbonyl compound having a structure as shown in formula (1):
wherein, R groups are ethyl (Et) and n-propyl [ ] n Pr, n-butyl ] n Bu) n-pentyl n Pent), benzyl (bzyl).
The invention provides a preparation method of the ionic type carbamyl iron carbonyl compound, the reaction route is shown as a formula (2), and the preparation method specifically comprises the following steps:
under the conditions of light-shielding, inert atmosphere, proper amount of organic solvent and temperature, [ Fe (CO) 4 Br 2 ]With an appropriate amount of an organic compoundThe amine reacts for a certain time, and the compound is prepared by washing, sedimentation, filtration and the like.
Preferably, the reaction atmosphere is inert atmosphere such as nitrogen or argon, the organic solvent is dry dichloromethane, chloroform, tetrahydrofuran, the reaction temperature is 0-30 ℃, and the reactant [ Fe (CO) ] 4 Br 2 ]The molar ratio of the catalyst to the organic amine is 1:4-1:6, and the reaction time is 5-60 minutes.
The invention at least comprises the following beneficial effects:
(1) The preparation process is simple and convenient, the reaction condition is mild, and the yield is high;
(2) The preparation method has certain applicability;
(3) The prepared ionic carbamoyl iron carbonyl compound has proper water solubility and certain thermal stability and has certain application prospect in CO medicinal research;
(4) The prepared ionic carbamyl iron carbonyl compound can be decomposed under certain conditions to obtain magnetic materials such as ferroferric oxide and the like, and has certain application in the field of ferromagnetic material research.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Drawings
FIG. 1 is a characteristic infrared spectrum of compounds 1-5 prepared in the present invention in methylene chloride.
FIG. 2 is a view showing the crystal structure of Compound 2 prepared in the present invention.
FIG. 3 is a graph of compound 2 at D prepared in accordance with the present invention 2 Infrared spectrum change pattern of CO released in O.
FIG. 4 is a diagram of Fe prepared in the present invention 3 O 4 XRD characterization of the material.
Detailed Description
The present invention will now be described more fully hereinafter with reference to the accompanying drawings. Those of ordinary skill in the art will be able to implement the invention based on these descriptions. Before describing the present invention with reference to the accompanying drawings, it should be noted in particular that: the technical solutions and technical features provided in the sections including the following description in the present invention may be combined with each other without conflict.
In addition, the embodiments of the present invention referred to in the following description are typically only some, but not all, embodiments of the present invention. Therefore, all other embodiments, which can be made by one of ordinary skill in the art without undue burden, are intended to be within the scope of the present invention, based on the embodiments of the present invention.
Example 1
Compound 1Is prepared from the following steps:
under the conditions of inert gas argon, dark place and ice bath and stirring, the [ Fe (CO) is dissolved into the solution 4 Br 2 ]To a solution of (0.131 g,0.4 mmol) in dichloromethane (15 mL) was added a solution of ethylamine (129. Mu.L, 2 mmol) in dichloromethane. The reaction was carried out for about 5 minutes, and the solution turned from reddish brown to pale yellow with the generation of bubbles. Filtering to remove insoluble solids, and removing solvent by rotary evaporation of mother liquor; dissolving the product with ethyl acetate, and filtering to remove insoluble substances to obtain the product. Yield: 0.130g (82% yield). Characterization data for compound 1 are as follows. FTIR (DCM, v) CO /cm -1 ):2026.2,1963.1。Microanalysis for C 11 H 27 FeN 4 O 3 Br·(CH 2 Cl 2 ) 1.4 ,calcd.(found):C％,28.75(28.66)；H％,5.80(6.10)；N％,10.82(11.22)。
Example 2
Compound 2Is prepared from the following steps:
under the conditions of inert gas argon, dark place and ice bath and stirring, the [ Fe (CO) is dissolved into the solution 4 Br 2 ]To a solution of (0.131 g,0.4 mmol) in dichloromethane (15 mL) was added a solution of propylamine (164. Mu.L, 2 mmol) in dichloromethane. The reaction was carried out for about 5 minutes and the solution turned from reddish brown to pale yellowAnd accompanied by bubble generation. Filtering to remove insoluble solids, and removing solvent by rotary evaporation of mother liquor; dissolving the product with ethyl acetate, and filtering to remove insoluble substances to obtain the product. Yield: 0.159g (88% yield). Characterization data for compound 2 are as follows. FTIR (DCM, v) CO /cm -1 ):2024.5,1958.2。Microanalys for C 15 H 35 BrFeN 4 O 3 ·(CH 2 Cl 2 ),calcd.(found):C％,35.58(35.34)；H％,6.90(6.85)；N％,10.37(9.87)。
Example 3
Compound 3Is prepared from the following steps:
under the conditions of inert gas argon, dark place and ice bath and stirring, the [ Fe (CO) is dissolved into the solution 4 Br 2 ]To a solution of (0.650 g,2 mmol) in dichloromethane (30 mL) was added a solution of n-butylamine (987. Mu.L, 10 mmol) in dichloromethane. The reaction was carried out for about 5 minutes, and the solution turned from reddish brown to pale yellow with the generation of bubbles. Filtering to remove insoluble solids, and removing solvent by rotary evaporation of mother liquor; dissolving the product with ethyl acetate, and filtering to remove insoluble substances to obtain the product. Yield: 0.918g (90% yield). Characterization data for compound 3 are as follows. FTIR (DCM, v) CO /cm -1 ):2024.6,1958.8。Microa nalysis for C 15 H 35 BrFeN 4 O 3 ·(H 2 O) 5 ,calcd.(found):C％,37.95(37.38)；H％,8.88(7.95)；N％,9.32(9.46)。
Example 4
Compound 4Is prepared from the following steps:
under the conditions of inert gas argon, dark place and ice bath and stirring, the [ Fe (CO) is dissolved into the solution 4 Br 2 ]To a solution of (0.328 g,1 mmol) in dichloromethane (20 mL) was added a solution of n-pentylamine (578. Mu.L, 5 mmol) in dichloromethane. The reaction was carried out for about 5 minutes, and the solution turned from reddish brown to pale yellow with the generation of bubbles. Filtering to remove insoluble solid, and rotary steaming mother liquorRemoving the solvent; dissolving the product with ethyl acetate, and filtering to remove insoluble substances to obtain the product. Yield: 0.42g (77% yield). Characterization data for compound 4 are as follows. FTIR (DCM, v) CO /cm -1 ):2024.0,1957.7。Microanalysis for C 23 H 51 BrFeN 4 O 3 ·(H 2 O) 5 ,calcd.(found):C％,43.20(42.79)；H％,9.30(8.67)；N％,8.76(8.84)。
Example 5
Compound 5Is prepared from the following steps:
under the conditions of inert gas argon, dark place and ice bath and stirring, the [ Fe (CO) is dissolved into the solution 4 Br 2 ]To a solution of (0.131 g,0.4 mmol) in dichloromethane (15 mL) was added a solution of benzylamine (219. Mu.L, 2 mmol) in dichloromethane. The reaction was carried out for about 5 minutes, and the solution turned from reddish brown to pale yellow with the generation of bubbles. Filtering to remove insoluble solids, and removing solvent by rotary evaporation of mother liquor; dissolving the product with ethyl acetate, and filtering to remove insoluble substances to obtain the product. Yield: 0.23g (90% yield). Characterization data for compound 5 are as follows. FTIR (DCM, v) CO /cm -1 ):2028.0,1964.8。Microanalysis for C 31 H 35 BrFeN 4 O 3 ,calcd.(found):C％,57.51(57.63)；H％,5.45(5.64)；N％,8.65(8.26)。
The carbonyl infrared characteristic absorption spectra of the above compounds 1-5 in methylene chloride solvent are shown in figure 1.
The crystal structure view of compound 2 is shown in fig. 2.
The invention also provides application of the ionic carbamoyl iron carbonyl compound in carbon monoxide slow release drug research.
Example 6: behavior of Compound 2 to release CO in deuterium Water solvent
Compound 2 (6.0 mg,0.015 mmol) was dissolved in deuterium water (D) at 37℃in a dark place in a water bath 2 O,3 mL). The change in concentration of the compound in the solution was monitored by infrared spectroscopy, see fig. 3. Its half-life for CO release is about 12 minutes.
The invention also provides application of the ionic carbamyl iron carbonyl compound in preparing ferromagnetic materials.
Example 7: preparation of Fe from Compound 1 3 O 4 Material
At room temperature in an open system environment, 50mL of deionized water (319 mg,0.8 mmol) was added, and after stirring for 40 minutes, the solid was collected by magnetic separation, washed and dried to obtain 55mg of a dark brown powder. X-ray powder diffraction characterization determines that the product is Fe with superparamagnetism 3 O 4 The material is shown in fig. 4.
Although embodiments of the present invention have been disclosed above, it is not limited to the details and embodiments shown, it is well suited to various fields of use for which the invention is suited, and further modifications may be readily made by one skilled in the art, and the invention is therefore not to be limited to the particular details and examples shown and described herein, without departing from the general concepts defined by the claims and the equivalents thereof.
Claims (5)
1. An ionic carbamoyl iron carbonyl compound is characterized by having a structure as shown in formula (1):
(1)
Wherein, R group is: ethyl, n-propyl, n-butyl, n-pentyl, benzyl.
2. The method for preparing an ionic carbamoyl iron carbonyl compound according to claim 1, which comprises:
in the dark, inert atmosphere, organic solvent and temperature, [ Fe (CO) 4 Br 2 ]Reacting with a certain amount of organic amine for a certain time, washing, settling and filtering to obtain the compound.
3. A process for the preparation of an ionic carbamoyl iron carbonyl compound according to claim 2, characterized in thatThe method comprises the following steps: the reaction atmosphere is nitrogen or argon, the organic solvent is dry dichloromethane, chloroform or tetrahydrofuran, and the reaction temperature is 0-30 o C, reactant [ Fe (CO) ] 4 Br 2 ]The molar ratio of the catalyst to the organic amine is 1:4-1:6, and the reaction time is 5-60 minutes.
4. Use of the ionic carbamoyl iron carbonyl compounds in carbon monoxide slow release research according to claim 1.
5. Use of the ionic carbamoyl iron carbonyl compounds according to claim 1 in the preparation of ferromagnetic materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111396543.6A CN114106059B (en) | 2021-11-23 | 2021-11-23 | Ionic carbamyl iron carbonyl compound, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111396543.6A CN114106059B (en) | 2021-11-23 | 2021-11-23 | Ionic carbamyl iron carbonyl compound, and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114106059A CN114106059A (en) | 2022-03-01 |
| CN114106059B true CN114106059B (en) | 2024-02-09 |
Family
ID=80440145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111396543.6A Active CN114106059B (en) | 2021-11-23 | 2021-11-23 | Ionic carbamyl iron carbonyl compound, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114106059B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108586546A (en) * | 2018-05-08 | 2018-09-28 | 嘉兴学院 | Containing three core iron carbonyl cationic compounds and its preparation method and application |
-
2021
- 2021-11-23 CN CN202111396543.6A patent/CN114106059B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108586546A (en) * | 2018-05-08 | 2018-09-28 | 嘉兴学院 | Containing three core iron carbonyl cationic compounds and its preparation method and application |
Non-Patent Citations (4)
| Title |
|---|
| Bioinspired CNP Iron(II) Pincers Relevant to [Fe]-Hydrogenase (Hmd): Effect of Dicarbonyl versus Monocarbonyl Motifs in H2 Activation and Transfer Hydrogenation;Zhu-Lin Xie等;《Inorg. Chem.》;第59卷;2548-2561 * |
| Brief survey of diiron and monoiron carbonyl complexes and their potentials as CO-releasing molecules (CORMs);X. Jiang等;《Coordination Chemistry Reviews》;第429卷;213634 * |
| Ferracyclic carbamoyl complexes related to the active site of [Fe]-hydrogenase;Peter J. Turrell等;《Dalton Trans.》;第42卷;8140-8146 * |
| The Third Hydrogenase: A Ferracyclic Carbamoyl with Close Structural Analogy to the Active Site of Hmd;Peter J. Turrell等;《Angew. Chem. Int. Ed.》;第49卷;7508-7511 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114106059A (en) | 2022-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stavropoulos et al. | Structural and reaction chemistry of nickel complexes in relation to carbon monoxide dehydrogenase: A reaction system simulating acetyl-coenzyme A synthase activity | |
| Bezaatpour et al. | Green oxidation of sulfides in solvent-free condition by reusable novel Mo (VI) complex anchored on magnetite as a high-efficiency nanocatalyst with eco-friendly aqueous H2O2 | |
| Das et al. | Modeling for the Active Site of Sulfite Oxidase: Synthesis, Characterization, and Reactivity of [MoVIO2 (mnt) 2] 2-(mnt2-= 1, 2-Dicyanoethylenedithiolate) | |
| Maurya et al. | Oxidovanadium (IV) and dioxidovanadium (V) complexes of hydrazones of 2-benzoylpyridine and their catalytic applications | |
| Maurya et al. | Synthesis, characterisation and catalytic potential of hydrazonato-vanadium (v) model complexes with [VO] 3+ and [VO 2]+ cores | |
| Maurya et al. | Mimicking peroxidase activity by a polymer-supported oxidovanadium (IV) Schiff base complex derived from salicylaldehyde and 1, 3-diamino-2-hydroxypropane | |
| CN111450894A (en) | Ce-based organic metal complex catalytic material and preparation and application thereof | |
| Wong et al. | Heterobimetallic cerium (IV) oxo clusters supported by a tripodal oxygen ligand | |
| Zhang et al. | Phosphine cleavage of iron (III)-bridged double cubanes: a new route to MoFe3S4 single cubanes | |
| CN114106059B (en) | Ionic carbamyl iron carbonyl compound, and preparation method and application thereof | |
| Sun et al. | Sulfur atom-directed metal–ligand synergistic catalysis in zirconium/hafnium-oxo clusters for highly efficient amine oxidation | |
| CN114478648A (en) | Pyridine-like pyrrole ruthenium complex, preparation method thereof and application of complex as electrocatalytic ammonia oxidation catalyst | |
| Bezaatpour et al. | Green, inexpensive, and fast conversion of sulfides to sulfoxides by multiusable Mo (VI) macrocyclic Schiff base complex supported on Fe3O4 nanoparticles in solvent-free conditions | |
| Adams et al. | Cluster synthesis. 36. New platinum-ruthenium and platinum-osmium carbonyl cluster complexes from the reactions of the complexes Pt2M4 (CO) 18 (M= ruthenium, osmium) with cycloocta-1, 5-diene in the presence of UV irradiation | |
| CN115894955A (en) | Zirconium-based metal organic framework material, and synthesis method and application thereof | |
| CN114314701B (en) | Preparation method of potassium ammonium platinum trichloride and application of potassium ammonium platinum trichloride in preparation of cis-ammonium-water-platinum complex | |
| CN114181264B (en) | Carbamoyl iron carbonyl compound and preparation method and application thereof | |
| CN107266374A (en) | A kind of monokaryon zinc super molecular complex and preparation method thereof | |
| CN113134391A (en) | Metal organic complex catalytic material with vanadium-tungsten bimetallic coordination | |
| Duan et al. | Synthesis, protonation and electrochemical properties of trinuclear NiFe2 complexes Fe2 (CO) 6 (μ3-S) 2 [Ni (Ph2PCH2) 2NR](R= n-Bu, Ph) with an internal pendant nitrogen base as a proton relay | |
| Alami et al. | “Click” Chemistry for the Functionalization of Graphene Oxide with Phosphorus Dendrons: Synthesis, Characterization and Preliminary Biological Properties | |
| Li et al. | Assembly of molecular squares and helical chain polymers of Mo (W)/Cu/S clusters using thiolato ligands as linkers | |
| Boutaybi et al. | Synthesis, Characterization, DFT, and Thermogravimetric Analysis of Neutral Co (II)/Pyrazole Complex, Catalytic Activity toward Catecholase and Phenoxazinone Oxidation. Crystals 2023, 13, 155 | |
| Nairn et al. | (N-Benzyl-bis-N′, N ″-salicylidene)-cis-1, 3, 5-triaminocyclohexane copper (ii): a novel catalyst for the aerobic oxidation of benzyl alcohol | |
| Liu et al. | Synthesis, structure and catalytic study of a new sandwiched-type vanadoselenite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |